Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $442.9100 (3.89%) ($442.9100 - $442.9100) on Tue. Feb. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.89% (three month average) | RSI | 85 | Latest Price | $442.9100(3.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2.2% a day on average for past five trading days. | Weekly Trend | REGN advances 4.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(41%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.945% in a week (0% probabilities). VIXM(-23%) VXX(-10%) TLT(-4%) SHY(-1%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.945% (StdDev 1.89%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $414.46(6.86%) | 10 Day Moving Average | $407.79(8.61%) | 20 Day Moving Average | $384.62(15.16%) | To recent high | 0% | To recent low | 31.8% | Market Cap | $46.961b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |